Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Ernexa Therapeutics Inc. (ERNA)

NASDAQ

$4.34

$-0.12

(-2.65%)

Regular Market

Ernexa Therapeutics Inc. (ERNA) Live Price Chart

Last updated: ⁦2026-09-04 19:21:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Ernexa Therapeutics Inc. (ERNA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.34, with a market capitalisation of $5.30M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.18 to $71.50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.30M
Open	$4.50
Day's High	$2,681.25
Day's Low	$3.18
Previous Close	$4.53
Volume	45.85K
Average Volume	--
P/E Ratio	--
52-Week High	$71.50
52-Week Low	$3.18
Dividend Yield	--
Earnings Date	--

Ernexa Therapeutics Inc. (ERNA) Stock Price Today

Ernexa Therapeutics Inc. (ERNA) is currently trading at $4.34 as of 2026-09-04 19:16:00, down 4.15% ($0.19) from the previous close of $4.53

During today's regular trading session, ERNA has traded between $3.18 and $2,681.25, with a trading volume of 45.85K shares. The current price is near the lower end of today's range.

Ernexa Therapeutics Inc. (ERNA) 7-Day Stock Price Change

Over the past seven days, Ernexa Therapeutics Inc. (ERNA) moved from $4.68 to $4.34, representing a decline of 7.22% ($0.34).

The stock traded between $4.31 and $4.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 27.22 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ERNA 52-Week Price Position

Position in Range: 1.7%

52W Low$3.18

52W High$71.50

ERNA is currently trading at $4.34, placing it 1.7% of the way from its 52-week low of $3.18 to its 52-week high of $71.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Ernexa Therapeutics Inc. (ERNA)?

Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.

Ernexa Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	5
Exchange	NASDAQ
Company Website	https://www.ernexatx.com

How to Buy Ernexa Therapeutics Inc. (ERNA) Stock on MEXC

Eligible investors can buy real shares of Ernexa Therapeutics Inc. (ERNA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ERNA and Place Your Order

Open the RealStocks trading page and search for ERNA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Ernexa Therapeutics Inc. (ERNA) stock price today?

Ernexa Therapeutics Inc. (ERNA) is currently trading at $ 4.34, down 4.15% ($0.19) from the previous close of $ 4.53. Intraday prices update in real time during regular trading hours.

2.Is ERNA stock going up or down today?

As of 2026-09-04 19:16:00, ERNA is trading at $ 4.34, down 4.15% ($0.19) from its previous close of $ 4.53. The stock has traded between $ 3.18 and $ 2,681.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is ERNA pre-market price?

As of 2026-09-04 19:16:00, ERNA is trading at $ 4.56 in pre-market trading, up 0.66% ($0.03) from the previous close of $ 4.53. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ERNA after-hours price?

As of 2026-09-04 19:16:00, ERNA is trading at -- in after-hours trading, -- from the regular-session close of $ 4.53. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ERNA stock trading now?

ERNA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ERNA sit relative to its 52-week high and low?

Over the past 52 weeks, ERNA has traded between a low of $ 3.18 and a high of $ 71.50. At $ 4.34, the stock is positioned 1.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Ernexa Therapeutics Inc. in?

Ernexa Therapeutics Inc. (ERNA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Ernexa Therapeutics Inc.'s market capitalisation and where is it listed?

Ernexa Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 5.30M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ERNA valued in terms of P/E ratio and EPS?

ERNA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -10.52. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Ernexa Therapeutics Inc. pay a dividend?

Ernexa Therapeutics Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.